المؤلفون: Yang J; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China., Le Y; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China., Wei T; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China., Wang K; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China., Yang K; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China., Xiao W; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China., Hong T; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China. Electronic address: tpho66@bjmu.edu.cn., Wei R; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China. Electronic address: weirui@bjmu.edu.cn.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2021 Feb; Vol. 35 (2), pp. 107797. Date of Electronic Publication: 2020 Nov 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Exenatide*/therapeutic use , Hypoglycemic Agents*/therapeutic use , Metabolomics*, Endothelium, Vascular/*physiopathology, Biomarkers ; Blood Glucose ; Glycated Hemoglobin/analysis ; Humans ; Hydroxyproline

المؤلفون: Philis-Tsimikas A; Scripps Whittier Diabetes Institute, La Jolla, CA, USA. Electronic address: philis-tsimikas.athena@scrippshealth.org., Wysham CH; Rockwood Clinic, Spokane, WA, USA., Hardy E; AstraZeneca, Gaithersburg, MD, USA., Han J; Pharmapace, San Diego, CA, USA., Iqbal N; AstraZeneca, Gaithersburg, MD, USA.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2019 Mar; Vol. 33 (3), pp. 223-230. Date of Electronic Publication: 2018 Dec 05.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Hypoglycemic Agents*, Diabetes Mellitus, Type 2/*drug therapy , Exenatide/*adverse effects , Exenatide/*therapeutic use, Adult ; Blood Pressure ; Body Weight ; Cardiovascular Diseases/prevention & control ; Diabetes Complications/prevention & control ; Diabetes Mellitus, Type 2/complications ; Female ; Glycated Hemoglobin/analysis ; Humans ; Lipids/blood ; Male ; Middle Aged ; Risk Factors ; Time Factors

المؤلفون: Trautmann ME; Diabetes Research, Hamburg, Germany. Electronic address: michael@trautmann-diabetes.com., Van Gaal L; Antwerp University Hospital, Antwerp, Belgium., Han J; Pharmapace, San Diego, CA, USA., Hardy E; AstraZeneca, Gaithersburg, MD, USA.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2017 Sep; Vol. 31 (9), pp. 1415-1422. Date of Electronic Publication: 2017 Jun 20.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*administration & dosage , Hypoglycemic Agents/*adverse effects , Peptides/*administration & dosage , Peptides/*adverse effects , Randomized Controlled Trials as Topic/*statistics & numerical data , Venoms/*administration & dosage , Venoms/*adverse effects, Adult ; Aged ; Diabetes Mellitus, Type 2/blood ; Drug Administration Schedule ; Exenatide ; Female ; Glycated Hemoglobin/analysis ; Humans ; Insulin Glargine/therapeutic use ; Insulin, Long-Acting/administration & dosage ; Insulin, Long-Acting/adverse effects ; Male ; Middle Aged ; Treatment Outcome

المؤلفون: Mazidi M; Key State Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China; Institute of Genetics and Developmental Biology, International College, University of Chinese Academy of Science, Beijing 100101, China. Electronic address: Moshen@genetics.ac.cn., Karimi E; Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Science, Mashhad, Iran., Rezaie P; Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Science, Mashhad, Iran., Ferns GA; Division of Medical Education, Brighton and Sussex Medical School, Rm 342, Mayfield House, University of Brighton, Brighton BN1 9PH, United Kingdom.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2017 Jul; Vol. 31 (7), pp. 1237-1242. Date of Electronic Publication: 2016 May 30.

نوع المنشور: Journal Article; Meta-Analysis; Review; Systematic Review

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: C-Reactive Protein/*analysis , Diabetes Mellitus, Type 2/*drug therapy , Down-Regulation/*drug effects , Glucagon-Like Peptide-1 Receptor/*antagonists & inhibitors , Hyperglycemia/*prevention & control , Hypoglycemia/*prevention & control , Hypoglycemic Agents/*therapeutic use, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Biomarkers/blood ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/immunology ; Diabetes Mellitus, Type 2/metabolism ; Exenatide ; Glucagon-Like Peptide-1 Receptor/metabolism ; Glycated Hemoglobin/analysis ; Humans ; Liraglutide/therapeutic use ; Peptides/therapeutic use ; Randomized Controlled Trials as Topic ; Venoms/therapeutic use

المؤلفون: Scalzo RL; Division of Endocrinology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Moreau KL; Division of Geriatrics, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215; Center for Women's Health Research, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215; VAMC-Geriatric Research Education and Clinical Center (GRECC), Denver, Colorado 80215., Ozemek C; Division of Geriatrics, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Herlache L; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., McMillin S; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Gilligan S; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Huebschmann AG; Center for Women's Health Research, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Bauer TA; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Dorosz J; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215., Reusch JE; Division of Endocrinology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215; Center for Women's Health Research, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215; Veterans Administration Medical Center (VAMC), Denver, Colorado 80215., Regensteiner JG; Center for Women's Health Research, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215; Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine (UCSOM), Denver, Colorado 80215. Electronic address: judy.regensteiner@ucdenver.edu.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2017 Feb; Vol. 31 (2), pp. 449-455. Date of Electronic Publication: 2016 Oct 07.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Diabetic Angiopathies/*prevention & control , Diabetic Cardiomyopathies/*prevention & control , Hypoglycemic Agents/*therapeutic use , Peptides/*therapeutic use , Vascular Stiffness/*drug effects , Venoms/*therapeutic use , Ventricular Dysfunction, Left/*prevention & control, Aged ; Arteries/drug effects ; Arteries/physiopathology ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/physiopathology ; Double-Blind Method ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/physiopathology ; Exenatide ; Exercise Tolerance/drug effects ; Female ; Follow-Up Studies ; Glucagon-Like Peptide 1/agonists ; Glucagon-Like Peptide 1/metabolism ; Heart Ventricles/drug effects ; Heart Ventricles/physiopathology ; Humans ; Hypoglycemic Agents/adverse effects ; Male ; Middle Aged ; Oxygen Consumption/drug effects ; Peptides/adverse effects ; Pulse Wave Analysis ; Sedentary Behavior ; Venoms/adverse effects ; Ventricular Dysfunction, Left/complications

المؤلفون: Liu J; Department of Endocrinology; Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China., Hu Y; Department of Endocrinology; Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China., Zhang H; Department of Endocrinology; Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China., Xu Y; Department of Endocrinology; Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China., Wang G; Department of Endocrinology; Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: drwg6688@126.com.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2016 Nov - Dec; Vol. 30 (8), pp. 1555-1559. Date of Electronic Publication: 2016 Jul 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Fibronectins/*blood , Hypoglycemic Agents/*therapeutic use , Obesity/*blood , Peptides/*therapeutic use , Venoms/*therapeutic use, Adult ; Case-Control Studies ; Diabetes Mellitus, Type 2/blood ; Exenatide ; Female ; Humans ; Male ; Middle Aged

المؤلفون: Quan H; Department of Endocrinology, People's Hospital of Hainan Province, Haikou, Hainan 570311, China. Electronic address: quanhuibiao_2015@163.com., Zhang H; Endocrine Laboratory, People's Hospital of Hainan Province, Haikou, Hainan 570311, China., Wei W; Department of Endocrinology, People's Hospital of Hainan Province, Haikou, Hainan 570311, China., Fang T; Department of Endocrinology, People's Hospital of Hainan Province, Haikou, Hainan 570311, China.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2016 May-Jun; Vol. 30 (4), pp. 686-92. Date of Electronic Publication: 2016 Jan 15.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Obesity Agents/*therapeutic use , Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*therapeutic use , Incretins/*therapeutic use , Metformin/*therapeutic use , Overweight/*drug therapy , Peptides/*therapeutic use , Venoms/*therapeutic use, Adult ; Anti-Obesity Agents/administration & dosage ; Anti-Obesity Agents/adverse effects ; Body Mass Index ; Cohort Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Drug Therapy, Combination/adverse effects ; Exenatide ; Female ; Follow-Up Studies ; Glycated Hemoglobin/analysis ; Humans ; Hyperglycemia/prevention & control ; Hypoglycemic Agents/adverse effects ; Incretins/administration & dosage ; Incretins/adverse effects ; Insulin Resistance ; Male ; Metformin/adverse effects ; Middle Aged ; Obesity/complications ; Obesity/drug therapy ; Overweight/complications ; Peptides/administration & dosage ; Peptides/adverse effects ; Sex Characteristics ; Venoms/administration & dosage ; Venoms/adverse effects ; Weight Loss/drug effects

المؤلفون: Jaiswal M; Department of Neurology, University of Michigan, Ann Arbor, MI., Martin CL; Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI., Brown MB; Department of Biostatistics, University of Michigan, Ann Arbor, MI., Callaghan B; Department of Neurology, University of Michigan, Ann Arbor, MI., Albers JW; Department of Neurology, University of Michigan, Ann Arbor, MI., Feldman EL; Department of Neurology, University of Michigan, Ann Arbor, MI., Pop-Busui R; Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: rpbusui@med.umich.edu.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2015 Nov-Dec; Vol. 29 (8), pp. 1287-94. Date of Electronic Publication: 2015 Jul 17.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Diabetic Neuropathies/*prevention & control , Glucagon-Like Peptide-1 Receptor/*agonists , Hyperglycemia/*prevention & control , Incretins/*therapeutic use , Peptides/*therapeutic use , Venoms/*therapeutic use, Aged ; Cohort Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Diabetic Neuropathies/epidemiology ; Diabetic Neuropathies/physiopathology ; Exenatide ; Female ; Glucagon-Like Peptide-1 Receptor/metabolism ; Glycated Hemoglobin/analysis ; Humans ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Incretins/adverse effects ; Insulin Glargine/adverse effects ; Insulin Glargine/therapeutic use ; Male ; Michigan/epidemiology ; Middle Aged ; Neural Conduction/drug effects ; Peptides/adverse effects ; Pilot Projects ; Prevalence ; Quality of Life ; Severity of Illness Index ; Venoms/adverse effects

المؤلفون: Henry RR; VA San Diego Healthcare System, San Diego, CA and University of California, San Diego, La Jolla, CA. Electronic address: rrhenry@vapop.ucsd.edu., Rosenstock J; Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX., Logan D; Medpace Clinical Pharmacology Unit, Cincinnati, OH., Alessi T; Intarcia Therapeutics Inc., Hayward, CA., Luskey K; Intarcia Therapeutics Inc., Hayward, CA., Baron MA; Intarcia Therapeutics Inc., Hayward, CA.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2014 May-Jun; Vol. 28 (3), pp. 393-8. Date of Electronic Publication: 2014 Jan 07.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Blood Glucose/*drug effects , Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*pharmacology , Metformin/*therapeutic use , Peptides/*pharmacology , Venoms/*pharmacology , Weight Loss/*drug effects, Adult ; Aged ; Blood Glucose/metabolism ; Body Weight/drug effects ; Body Weight/physiology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/physiopathology ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Exenatide ; Female ; Glycated Hemoglobin/drug effects ; Glycated Hemoglobin/metabolism ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Infusions, Subcutaneous ; Longitudinal Studies ; Male ; Middle Aged ; Peptides/administration & dosage ; Peptides/adverse effects ; Treatment Outcome ; Venoms/administration & dosage ; Venoms/adverse effects ; Weight Loss/physiology

المؤلفون: Grant P; Royal Sussex County Hospital, Eastern Road, Brighton, 01273 696955 BN2 5BE, United Kingdom. drpaul.grant@doctors.org.uk, Lipscomb D, Quin J

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2011 Jul-Aug; Vol. 25 (4), pp. 244-6. Date of Electronic Publication: 2011 May 20.

نوع المنشور: Controlled Clinical Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life*, Diabetes Mellitus, Type 2/*drug therapy , Diabetes Mellitus, Type 2/*psychology , Glucagon-Like Peptide 1/*analogs & derivatives , Hypoglycemic Agents/*therapeutic use , Incretins/*therapeutic use, Aged ; Anxiety/prevention & control ; Body Mass Index ; Depression/prevention & control ; Diabetes Mellitus, Type 2/blood ; Exenatide ; Female ; Glucagon-Like Peptide 1/adverse effects ; Glucagon-Like Peptide 1/therapeutic use ; Glycated Hemoglobin/analysis ; Humans ; Hyperglycemia/prevention & control ; Hypoglycemic Agents/adverse effects ; Incretins/adverse effects ; Male ; Middle Aged ; Patient Satisfaction ; Peptides/adverse effects ; Peptides/therapeutic use ; Psychiatric Status Rating Scales ; United Kingdom ; Venoms/adverse effects ; Venoms/therapeutic use ; Weight Loss/drug effects